Oncternal Therapeutics In... (ONCT)
NASDAQ: ONCT
· Real-Time Price · USD
0.53
-0.16 (-23.63%)
At close: Dec 02, 2024, 10:00 PM
Oncternal Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.12 | -0.61 | -0.82 | -0.86 | -0.45 | -0.57 | -1.01 | -1.3 | -6.69 | -7.69 | -11.33 | -22.65 | -34.89 | -49.82 | -112.7 |
PEG Ratio | 0.11 | -0.29 | 0.09 | 0.12 | -0.05 | 0.03 | -0.48 | -0.00 | 0.96 | -0.43 | -0.51 | 1.36 | -1.4 | -1.68 | -0.35 |
PS Ratio | n/a | 25.94 | 48.36 | 106.41 | 98.82 | 193.89 | n/a | 330.85 | 750.83 | 1.87K | 600.47 | 1.32K | 631.51 | 1.73K | 3.58K |
PB Ratio | 0.43 | 1.32 | 1.20 | 1.05 | -0.09 | -0.11 | 0.88 | -0.36 | 4.18 | 4.83 | 5.59 | -6.41 | 14.22 | 14.93 | 24.76 |
P/FCF Ratio | -0.56 | -3.57 | -3.7 | -4.92 | -3.21 | -2.22 | -4.21 | -6.28 | -23.97 | -50.17 | -52.05 | -110.57 | -210.64 | -201.21 | -448 |
P/OCF Ratio | -0.56 | -3.57 | -3.7 | -4.92 | -3.21 | -2.22 | -4.21 | -6.28 | -23.97 | -50.17 | -52.05 | -110.57 | -210.64 | -201.21 | -448 |
OCF/S Ratio | n/a | -7.27 | -13.07 | -21.61 | -30.8 | -87.39 | n/a | -52.64 | -31.32 | -37.33 | -11.54 | -11.9 | -3 | -8.62 | -8 |
Debt / Equity Ratio | 0.02 | 0.01 | 0.01 | 0.01 | -0.00 | -0.00 | 0.00 | -0.00 | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 | 0.00 | 0.00 |
Quick Ratio | 2.39 | 2.89 | 4.66 | 6.94 | 8.28 | 10.42 | 10.55 | 8.75 | 9.81 | 10.78 | 16.07 | 16.99 | 17.10 | 18.24 | 19.76 |
Current Ratio | 2.39 | 2.89 | 4.66 | 6.94 | 8.25 | 10.37 | 10.55 | 8.76 | 9.81 | 10.78 | 16.07 | 16.99 | 17.10 | 18.24 | 19.76 |
Asset Turnover | n/a | 0.03 | 0.02 | 0.01 | 0.00 | 0.00 | n/a | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.93 | -0.54 | -0.37 | -0.3 | 0.05 | 0.05 | -0.22 | 0.07 | -0.16 | -0.16 | -0.12 | 0.07 | -0.1 | -0.07 | -0.05 |
Return on Assets | -0.54 | -0.36 | -0.29 | -0.25 | -0.23 | -0.18 | -0.2 | -0.16 | -0.14 | -0.14 | -0.12 | -0.09 | -0.1 | -0.07 | -0.05 |
Return on Invested Capital | -0.93 | -0.55 | -0.38 | -0.3 | -0.27 | -0.21 | -0.23 | -0.19 | -0.16 | -0.16 | -0.12 | -0.09 | -0.1 | -0.07 | -0.05 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | -6.37 | -9.65 | -21.46 | 0.58 | 0.65 | n/a | 0.80 | 0.91 | 0.66 | 0.94 | -5.65 | -3.21 | -4.88 | -4.23 |
Net Profit Margin | n/a | -10.69 | -14.74 | -30.86 | -55.09 | -84.58 | n/a | -63.65 | -28.08 | -60.91 | -13.25 | -14.52 | -4.53 | -8.7 | -7.95 |
Pretax Profit Margin | n/a | -10.69 | -14.74 | -30.86 | -55.09 | -84.58 | n/a | -66.67 | -29.12 | -61.47 | -13.28 | -14.52 | -4.53 | -8.7 | -7.95 |
Operating Profit Margin | n/a | -11.06 | -15.43 | -32.44 | -58.04 | -90.05 | n/a | -69.68 | -29.65 | -61.75 | -13.27 | -14.53 | -4.53 | -8.71 | -7.97 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | -11.06 | n/a | -30.95 | -58.04 | -90.05 | n/a | -70.95 | -29.65 | -61.75 | -13.29 | -14.53 | -4.53 | -8.71 | -7.97 |